Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.59 | -0.44 | -2.22 | 1.83K | -60.94 | -45 |
PEG Ratio | 0.28 | 0.02 | 0 | -18.23 | 1.83 | -0.16 |
PS Ratio | 6.54 | 0.06 | 0.46 | 0.48 | 3.18 | 3.40 |
PB Ratio | -209.23 | 6.46 | 2.64 | 0.98 | 6.20 | 22.72 |
P/FCF Ratio | -118.37 | -0.76 | -3.68 | -1.79 | -18.07 | -930.72 |
P/OCF Ratio | -133.77 | -0.87 | -4.14 | -1.94 | -19.76 | 1.26K |
OCF/S Ratio | -4.89 | -6.75 | -11.20 | -24.46 | -16.10 | 0.27 |
Debt / Equity Ratio | -6.60 | 34.31 | 2.10 | 0.88 | 0 | 0.42 |
Quick Ratio | 1.35 | 1.96 | 3.73 | 4.08 | 4.95 | 0.89 |
Current Ratio | 1.59 | 2.15 | 4.12 | 4.39 | 5.17 | 1.04 |
Asset Turnover | 3.05 | 2.28 | 1.55 | 0.96 | 1 | 2.85 |
Interest Coverage | -3.20 | -8.02 | -11.36 | -20.08 | -143.31 | -23.62 |
Return on Equity | 385.53% | -1.8K% | -145.67% | 0.12% | -10.49% | -50.96% |
Return on Assets | -36.81% | -37.44% | -39.70% | 0.06% | -5.37% | -21.80% |
Return on Invested Capital | -35.70% | -47.23% | -42.58% | 57.65% | -24.86% | -18.66% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 15.20% | 13.73% | 18.37% | 20.63% | 20.12% | 19.67% |
Net Profit Margin | -12.06% | -16.44% | -25.62% | 0.06% | -5.38% | -7.64% |
Pretax Profit Margin | -12.08% | -16.44% | -25.63% | -0.04% | -5.71% | -7.90% |
Operating Profit Margin | -7.18% | -15.28% | -23.75% | -32.46% | -22.59% | -4.37% |
FCF Margin | -5.53% | -7.71% | -12.61% | -26.65% | -17.60% | -0.37% |
EBITDA Margin | -8.46% | -12.93% | -16.74% | -26.77% | -20.71% | -6.02% |
Add to Watchlist
Select watchlists to add or remove TOI